#wto-trips-compliance

#wto-trips-compliance

"We worked hard," WTO Director-General Ngozi Okonjo-Iweala said, adding that the US and Brazil in particular "need more time" to work out their differences over the agreement to impose levies on cross-border online orders.

According to the patent, a specific crystalline form of the drug known as polymorph C may be more effective than other versions because it is absorbed more efficiently by the body. The patent also notes that laboratory studies showed the drug reduced tumor growth and helped mice with brain tumors live longer, prompting early clinical trials to test whether the treatment is safe and effective in humans.

WIPO is not merely a distant UN bureaucracy; it is a dynamic, fee-driven organization that has been undergoing significant operational and cultural transformation in recent years.

Data has become the defining currency of global power. The nations and organizations that can manage, protect, and share it responsibly will shape the future of economic resilience and international cooperation. In an era where artificial intelligence and digital interdependence connect every market and mission, the ability to build and maintain trust in data is now a central pillar of both commerce and diplomacy.

The U.S. International Trade Commission (ITC)-an agency with the extraordinary power to block imports and, in turn, influence the direction of American technology policy-has drifted out of that balance. To align with the Trump Administration's intellectual property priorities and pro-investment agenda, the ITC is in urgent need of reform.

This week in Other Barks & Bites, IPWatchdog's IP news roundup: the House of Representatives passes drug patent legislation, while antitrust legislation targeting patent-related activities is introduced into the Senate and the Trump administration mandates pricing information for pharmaceutical ads; the Patent Trial and Appeal Board (PTAB) issues a pair of precedential decisions on cases with multiple petitions; the USPTO issues marijuana-related trademark guidelines and a notice on modifying patent term adjustment practices;

There's a crisis of creativity in mainstream American culture. We have fewer and fewer studios and record labels fewer and fewer platforms online that serve independent artists and creators. At its core, copyright is a monopoly right on creative output and expression. It's intended to allow people who make things to make a living through those things, to incentivize creativity. To square the circle that is "exclusive control over expression" and "free speech," we have fair use.

For those in the patent law world who may have been hiding under a rock, we have been flooded recently with lower court rulings on patent-eligibility under 35 U.S.C. § 101 after Alice Corp. v. CLS Bank International. Like a tsunami, these lower court rulings are uniformly sweeping away any patent in its wake as being directed to merely an "abstract idea" that doesn't provide "something more."

Yesterday, the European Union Intellectual Property Office (EUIPO) and the Organisation for Economic Co-operation and Development (OECD) published the results of a joint study detailing the close connection between illicit trade in counterfeits and labor exploitation. The joint study shows clear, repeated associations between the intensity of counterfeit trade and abusive labor conditions, strongly suggesting that such conditions structurally enable the production and distribution of counterfeits.

Regents of the University of California ("Regents") and Broad Institute were engaged in a patent interference proceeding involving the adaptation of CRISPR systems to edit eukaryotic DNA. Both parties were engaged in extensive testing related to editing eukaryotic DNA during the time of the invention, and both filed multiple patent applications that became the subjects of the patent interference proceedings.

In a recent Tradespace and Above the Law survey, two-thirds of companies that draft patents in-house described IP as a value driver, while 71 percent of companies that outsource drafting viewed IP as a cost. When drafting and prosecution move inside, IP teams work closer to engineers and product leaders. This proximity improves invention quality, strengthens claim strategy, and aligns patent decisions with product direction, market timing, and business priorities.